Insider Transactions for Intra-Cellular Therapies, Inc. (ITCI)

Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Alafi Christopher D Director May 14, 2019 Buy $12.56 100,000 1,256,350 4,053,270 May 15, 2019, 06:03 PM
Alafi Christopher D Director Mar 31, 2019 Option Exercise $12.18 1,190 14,494 750,106 Apr 02, 2019, 07:03 PM
VAN NOSTRAND ROBERT L Director Mar 31, 2019 Option Exercise $12.18 478 5,822 5,433 Apr 02, 2019, 06:59 PM
RIGGS RORY B Director Mar 31, 2019 Option Exercise $12.18 1,190 14,494 41,247 Apr 02, 2019, 06:56 PM
LERNER RICHARD A Director Mar 31, 2019 Option Exercise $12.18 1,128 13,739 68,039 Apr 02, 2019, 06:52 PM
Hineline Lawrence J. SVP of Finance CFO Feb 27, 2019 Option Exercise $2.74 10,400 28,496 26,232 Mar 01, 2019, 07:41 PM
Hineline Lawrence J. SVP of Finance CFO Feb 27, 2019 Sale $15.00 1,000 15,000 25,232 Mar 01, 2019, 07:41 PM
Mates Sharon Chairman, President & CEO Jan 07, 2019 Sale $12.43 6,604 82,088 1,138,707 Jan 08, 2019, 09:28 PM
Mates Sharon Chairman, President & CEO Jan 04, 2019 Sale $11.45 45,598 522,222 1,152,850 Jan 08, 2019, 09:28 PM
Halstead Michael EVP and General Counsel Jan 07, 2019 Sale $12.42 3,108 38,601 191 Jan 08, 2019, 09:24 PM
Halstead Michael EVP and General Counsel Jan 04, 2019 Sale $11.46 21,458 245,817 8,697 Jan 08, 2019, 09:24 PM
Hineline Lawrence J. SVP of Finance CFO Jan 07, 2019 Sale $12.42 3,108 38,601 17,032 Jan 08, 2019, 09:21 PM
Hineline Lawrence J. SVP of Finance CFO Jan 04, 2019 Sale $11.45 21,458 245,782 21,882 Jan 08, 2019, 09:21 PM
Vanover Kimberly E. SVP, Early Stage Clinical Dev. Jan 07, 2019 Sale $12.29 592 7,276 27,068 Jan 08, 2019, 09:19 PM
Vanover Kimberly E. SVP, Early Stage Clinical Dev. Jan 04, 2019 Sale $11.47 9,564 109,704 29,844 Jan 08, 2019, 09:19 PM
Davis Robert E SVP, Chief Scientific Officer Jan 04, 2019 Sale $11.46 9,564 109,630 46,691 Jan 08, 2019, 09:16 PM
Mates Sharon Chairman, President & CEO Jan 02, 2019 Sale $11.09 17,478 193,831 1,138,707 Jan 03, 2019, 09:02 PM
Halstead Michael EVP and General Counsel Jan 02, 2019 Sale $11.09 7,807 86,580 191 Jan 03, 2019, 08:58 PM
Vanover Kimberly E. SVP, Early Stage Clinical Dev. Jan 02, 2019 Sale $11.10 4,834 53,657 16,861 Jan 03, 2019, 08:46 PM
Davis Robert E SVP, Chief Scientific Officer Jan 02, 2019 Sale $11.11 4,834 53,706 34,744 Jan 03, 2019, 08:42 PM
Hineline Lawrence J. SVP of Finance CFO Jan 02, 2019 Sale $11.09 7,807 86,580 17,032 Jan 03, 2019, 08:23 PM
VAN NOSTRAND ROBERT L Director Dec 31, 2018 Option Exercise $11.39 512 5,832 4,955 Jan 03, 2019, 08:19 PM
RIGGS RORY B Director Dec 31, 2018 Option Exercise $11.39 1,273 14,499 40,057 Jan 03, 2019, 08:15 PM
LERNER RICHARD A Director Dec 31, 2018 Option Exercise $11.39 1,207 13,748 11,430 Jan 03, 2019, 08:11 PM
Alafi Christopher D Director Dec 31, 2018 Option Exercise $11.39 1,273 14,499 748,916 Jan 03, 2019, 08:05 PM
Mates Sharon Chairman, President & CEO Dec 10, 2018 Option Exercise $1.50 50,000 75,000 1,138,707 Dec 11, 2018, 05:55 PM
Davis Robert E SVP, Chief Scientific Officer Dec 06, 2018 Sale $13.53 899 12,163 30,256 Dec 07, 2018, 04:44 PM
MARCUS JOEL S Director Nov 12, 2018 Sale $17.94 7,000 125,580 78,742 Nov 13, 2018, 05:34 PM
MARCUS JOEL S Director Nov 09, 2018 Sale $18.24 25,000 456,000 85,742 Nov 13, 2018, 05:34 PM
LERNER RICHARD A Director Oct 22, 2018 Option Exercise $1.50 12,500 18,750 66,911 Oct 24, 2018, 04:33 PM
LERNER RICHARD A Director Sep 30, 2018 Option Exercise $21.70 633 13,736 54,411 Oct 02, 2018, 08:11 PM
RIGGS RORY B Director Sep 30, 2018 Option Exercise $21.70 668 14,496 38,784 Oct 02, 2018, 08:08 PM
VAN NOSTRAND ROBERT L Director Sep 30, 2018 Option Exercise $21.70 268 5,816 4,443 Oct 02, 2018, 08:06 PM
Alafi Christopher D Director Sep 30, 2018 Option Exercise $21.70 668 14,496 747,643 Oct 02, 2018, 08:01 PM
LERNER RICHARD A Director Jun 29, 2018 Option Exercise $17.67 778 13,747 53,778 Jul 03, 2018, 04:27 PM
Alafi Christopher D Director Jun 29, 2018 Option Exercise $17.67 820 14,489 746,975 Jul 03, 2018, 12:00 AM
VAN NOSTRAND ROBERT L Director Jun 29, 2018 Option Exercise $17.67 282 4,983 4,175 Jul 03, 2018, 12:00 AM
RIGGS RORY B Director Jun 29, 2018 Option Exercise $17.67 820 14,489 38,116 Jul 03, 2018, 12:00 AM
VAN NOSTRAND ROBERT L Director Mar 30, 2018 Option Exercise $21.05 237 4,989 3,893 Apr 03, 2018, 04:19 PM
LERNER RICHARD A Director Mar 30, 2018 Option Exercise $21.05 653 13,746 10,223 Apr 03, 2018, 12:00 AM
Alafi Christopher D Director Mar 30, 2018 Option Exercise $21.05 688 14,482 746,155 Apr 03, 2018, 12:00 AM
RIGGS RORY B Director Mar 30, 2018 Option Exercise $21.05 688 14,482 37,296 Apr 03, 2018, 12:00 AM
Hineline Lawrence J. VP of Finance CFO Feb 16, 2018 Sale $20.01 16,319 326,543 17,032 Feb 20, 2018, 04:38 PM
Hineline Lawrence J. VP of Finance CFO Feb 15, 2018 Sale $20.03 33,381 668,621 33,351 Feb 20, 2018, 04:38 PM
Halstead Michael SVP and General Counsel Jan 22, 2018 Sale $18.03 25,500 459,765 191 Jan 24, 2018, 07:11 PM
Vanover Kimberly E. SVP, Clinical Development Jan 08, 2018 Sale $17.46 772 13,479 12,373 Jan 10, 2018, 09:05 PM
Mates Sharon Chairman, President & CEO Jan 08, 2018 Sale $17.48 6,604 115,438 1,088,707 Jan 10, 2018, 09:01 PM
Mates Sharon Chairman, President & CEO Jan 05, 2018 Sale $17.08 11,257 192,270 1,095,311 Jan 05, 2018, 08:19 PM
Vanover Kimberly E. SVP, Clinical Development Jan 05, 2018 Sale $17.37 1,185 20,583 13,145 Jan 05, 2018, 08:14 PM
Davis Robert E SVP, Chief Scientific Officer Jan 04, 2018 Sale $15.60 1,115 17,394 29,397 Jan 05, 2018, 08:09 PM
Hineline Lawrence J. VP of Finance CFO Jan 04, 2018 Sale $15.67 3,192 50,019 68,602 Jan 05, 2018, 08:06 PM
Hineline Lawrence J. VP of Finance CFO Jan 05, 2018 Sale $17.49 1,870 32,706 66,732 Jan 05, 2018, 08:06 PM
Halstead Michael SVP and General Counsel Jan 05, 2018 Sale $17.49 1,560 27,284 25,691 Jan 05, 2018, 08:03 PM
Halstead Michael SVP and General Counsel Jan 04, 2018 Sale $15.75 2,660 41,895 27,251 Jan 05, 2018, 08:03 PM
VAN NOSTRAND ROBERT L Director Dec 29, 2017 Option Exercise $14.48 345 4,996 3,656 Jan 03, 2018, 06:10 PM
RIGGS RORY B Director Dec 29, 2017 Option Exercise $14.48 1,001 14,494 36,608 Jan 03, 2018, 06:05 PM
LERNER RICHARD A Director Dec 29, 2017 Option Exercise $14.48 949 13,742 9,570 Jan 03, 2018, 06:01 PM
Alafi Christopher D Director Dec 29, 2017 Option Exercise $14.48 1,001 14,494 745,467 Jan 03, 2018, 05:59 PM
VAN NOSTRAND ROBERT L Director Dec 29, 2017 Buy $14.48 345 4,996 3,656 Jan 03, 2018, 04:31 PM
LERNER RICHARD A Director Dec 29, 2017 Buy $14.48 949 13,742 9,570 Jan 03, 2018, 04:29 PM
RIGGS RORY B Director Dec 29, 2017 Buy $14.48 1,001 14,494 36,608 Jan 03, 2018, 12:00 AM
Alafi Christopher D Director Dec 29, 2017 Buy $14.48 1,001 14,494 745,467 Jan 03, 2018, 12:00 AM
LERNER RICHARD A Director Dec 11, 2017 Option Exercise $1.50 12,500 18,750 60,000 Dec 13, 2017, 04:52 PM
LERNER RICHARD A Director Dec 11, 2017 Sale $15.09 7,000 105,630 53,000 Dec 13, 2017, 04:52 PM
Davis Robert E SVP, Chief Scientific Officer Dec 05, 2017 Sale $15.00 650 9,750 27,864 Dec 06, 2017, 06:33 PM
Alafi Christopher D Director Nov 22, 2017 Buy $15.55 10,000 155,500 744,466 Nov 27, 2017, 04:31 PM
Mates Sharon Chairman, President & CEO Oct 30, 2017 Option Exercise $1.50 18,750 28,125 1,107,457 Nov 01, 2017, 08:04 PM
Mates Sharon Chairman, President & CEO Oct 30, 2017 Sale $15.75 18,750 295,313 1,088,707 Nov 01, 2017, 08:04 PM
ALAFI MOSHE 10% Owner Oct 02, 2017 Buy $15.50 258,065 4,000,008 3,953,270 Oct 03, 2017, 06:11 PM
Alafi Christopher D Director Oct 02, 2017 Buy $15.50 258,065 4,000,008 3,953,270 Oct 03, 2017, 06:10 PM
ALAFI CAPITAL CO LLC 10% Owner Oct 02, 2017 Buy $15.50 258,065 4,000,008 3,953,270 Oct 03, 2017, 06:08 PM
MARCUS JOEL S Director Jan 26, 2017 Option Exercise $2.60 95,000 247,450 116,671 Jan 30, 2017, 06:13 PM
Vanover Kimberly E. SVP, Clinical Development Jan 05, 2017 Sale $16.59 800 13,272 10,128 Jan 09, 2017, 05:34 PM
Mates Sharon Chairman, President & CEO Jan 05, 2017 Sale $16.55 4,081 67,541 1,088,707 Jan 09, 2017, 05:31 PM
Hineline Lawrence J. VP of Finance CFO Jan 05, 2017 Sale $16.58 1,918 31,800 63,389 Jan 09, 2017, 05:29 PM
Halstead Michael SVP and General Counsel Jan 05, 2017 Sale $16.55 1,601 26,497 21,506 Jan 09, 2017, 05:27 PM
Vanover Kimberly E. SVP, Clinical Development Dec 15, 2016 Option Exercise $1.46 18,750 27,425 12,500 Dec 19, 2016, 05:50 PM
Vanover Kimberly E. SVP, Clinical Development Dec 15, 2016 Sale $15.23 9,375 142,773 9,375 Dec 19, 2016, 05:50 PM
ALAFI MOSHE 10% Owner Dec 07, 2016 Buy $16.14 20,826 336,038 3,695,205 Dec 07, 2016, 04:35 PM
ALAFI MOSHE 10% Owner Dec 06, 2016 Buy $16.33 44,174 721,445 3,674,379 Dec 07, 2016, 04:35 PM
Alafi Christopher D Director Dec 06, 2016 Buy $16.33 44,174 721,445 3,674,379 Dec 07, 2016, 04:32 PM
Alafi Christopher D Director Dec 07, 2016 Buy $16.14 20,826 336,038 3,695,205 Dec 07, 2016, 04:32 PM
ALAFI CAPITAL CO LLC 10% Owner Dec 07, 2016 Buy $16.14 20,826 336,038 3,695,205 Dec 07, 2016, 04:21 PM
ALAFI CAPITAL CO LLC 10% Owner Dec 06, 2016 Buy $16.33 44,174 721,445 3,674,379 Dec 07, 2016, 04:21 PM
ALAFI MOSHE 10% Owner Nov 14, 2016 Buy $14.50 34,000 492,969 3,630,205 Nov 17, 2016, 04:35 PM
ALAFI CAPITAL CO LLC 10% Owner Nov 14, 2016 Buy $14.50 34,000 492,969 3,630,205 Nov 17, 2016, 04:34 PM
Alafi Christopher D Director Nov 14, 2016 Buy $14.50 34,000 492,969 3,630,205 Nov 17, 2016, 04:32 PM
RIGGS RORY B Director Feb 05, 2014 Buy $17.50 14,285 249,988 26,091 Apr 20, 2016, 04:30 PM
RIGGS RORY B Director Feb 05, 2014 Buy $17.50 14,286 250,005 226,670 Apr 20, 2016, 04:30 PM
Alafi Christopher D Director Feb 29, 2016 Buy $29.70 100,000 2,970,300 728,828 Feb 29, 2016, 05:32 PM
LERNER RICHARD A Director Feb 18, 2016 Option Exercise $1.36 10,000 13,600 47,500 Feb 19, 2016, 04:25 PM
VAN NOSTRAND ROBERT L Director Dec 31, 2015 Option Exercise $53.79 69 3,712 1,365 Jan 05, 2016, 07:09 PM
RIGGS RORY B Director Dec 31, 2015 Option Exercise $53.79 197 10,597 15,679 Jan 05, 2016, 05:13 PM
MARCUS JOEL S Director Dec 31, 2015 Option Exercise $53.79 199 10,704 18,921 Jan 05, 2016, 05:11 PM
Alafi Christopher D Director Dec 31, 2015 Option Exercise $53.79 195 10,489 628,828 Jan 05, 2016, 05:00 PM
LERNER RICHARD A Director Dec 31, 2015 Option Exercise $53.79 188 10,113 3,266 Jan 05, 2016, 04:59 PM
Mates Sharon Chairman, President & CEO Dec 11, 2015 Option Exercise $1.12 68,750 77,125 1,137,685 Dec 15, 2015, 08:27 PM
Mates Sharon Chairman, President & CEO Dec 11, 2015 Sale $53.87 51,500 2,774,441 1,107,639 Dec 15, 2015, 08:27 PM
Hineline Lawrence J. VP of Finance CFO Nov 24, 2015 Option Exercise $0.60 5,000 3,000 64,700 Dec 15, 2015, 08:25 PM
Hineline Lawrence J. VP of Finance CFO Dec 15, 2015 Option Exercise $1.45 35,000 50,750 74,700 Dec 15, 2015, 08:25 PM
Hineline Lawrence J. VP of Finance CFO Dec 14, 2015 Option Exercise $0.60 7,500 4,500 72,200 Dec 15, 2015, 08:25 PM
Hineline Lawrence J. VP of Finance CFO Dec 15, 2015 Sale $51.97 22,500 1,169,226 63,464 Dec 15, 2015, 08:25 PM
Hineline Lawrence J. VP of Finance CFO Dec 14, 2015 Sale $50.94 22,500 1,146,140 62,307 Dec 15, 2015, 08:25 PM
MARCUS JOEL S Director Dec 07, 2015 Sale $53.17 40,000 2,126,628 1,238,781 Dec 08, 2015, 05:30 PM
MARCUS JOEL S Director Dec 04, 2015 Sale $55.96 30,000 1,678,800 1,253,856 Dec 08, 2015, 05:30 PM
MARCUS JOEL S Director Dec 08, 2015 Sale $54.80 22,700 1,243,960 1,191,156 Dec 08, 2015, 05:30 PM
Hineline Lawrence J. VP of Finance CFO Nov 24, 2015 Sale $55.00 5,000 275,000 59,700 Nov 27, 2015, 08:29 AM
Fienberg Allen A. VP of Business Development Sep 09, 2015 Option Exercise $1.36 12,500 17,000 295,000 Sep 11, 2015, 04:53 PM
Fienberg Allen A. VP of Business Development Aug 19, 2015 Sale $30.30 10,000 303,000 198,023 Sep 11, 2015, 04:53 PM
Fienberg Allen A. VP of Business Development Aug 21, 2015 Sale $30.30 200 6,060 197,823 Sep 11, 2015, 04:53 PM
Wennogle Lawrence P. Vice President, Drug Discovery Jun 08, 2015 Sale $26.84 25,000 671,000 126,500 Jun 09, 2015, 05:04 PM
Wennogle Lawrence P. Vice President, Drug Discovery May 19, 2015 Option Exercise $1.23 47,500 58,250 151,500 May 20, 2015, 05:19 PM
Fienberg Allen A. VP of Business Development Mar 31, 2015 Option Exercise $0.60 12,500 7,500 282,500 Apr 02, 2015, 04:59 PM
MARCUS JOEL S Director Mar 31, 2015 Option Exercise $1.23 15,000 18,400 18,118 Apr 02, 2015, 04:58 PM
Alafi Christopher D Director Mar 11, 2015 Buy $24.00 625,000 15,000,000 627,604 Mar 12, 2015, 06:24 PM
Fienberg Allen A. VP of Business Development Jan 14, 2015 Sale $19.00 5,000 95,000 270,000 Jan 16, 2015, 04:31 PM
Hineline Lawrence J. VP of Finance CFO Dec 09, 2014 Sale $16.52 11,535 190,558 64,700 Dec 10, 2014, 05:11 PM
Hineline Lawrence J. VP of Finance CFO Dec 08, 2014 Sale $16.91 10,965 185,418 76,235 Dec 10, 2014, 05:11 PM
Hineline Lawrence J. VP of Finance CFO Dec 02, 2014 Option Exercise $0.50 37,200 18,600 87,200 Dec 03, 2014, 05:43 PM
Alafi Christopher D Director Dec 01, 2014 Buy $14.75 1,422 20,975 3,596,205 Dec 03, 2014, 05:42 PM
ALAFI MOSHE 10% Owner Dec 01, 2014 Buy $14.75 1,422 20,975 3,596,205 Dec 03, 2014, 05:40 PM
ALAFI CAPITAL CO LLC 10% Owner Dec 01, 2014 Buy $14.75 1,422 20,975 3,596,205 Dec 03, 2014, 05:39 PM
ALAFI CAPITAL CO LLC 10% Owner Nov 28, 2014 Buy $14.75 35,000 516,250 3,594,783 Nov 28, 2014, 04:42 PM
ALAFI MOSHE 10% Owner Nov 28, 2014 Buy $14.75 35,000 516,250 3,594,783 Nov 28, 2014, 04:38 PM
Alafi Christopher D Director Nov 28, 2014 Buy $14.75 35,000 516,250 3,594,783 Nov 28, 2014, 04:36 PM
Mates Sharon Chairman, President & CEO Nov 25, 2014 Option Exercise $0.50 50,000 25,000 1,103,935 Nov 28, 2014, 04:31 PM
Mates Sharon Chairman, President & CEO Nov 28, 2014 Sale $14.75 35,000 516,250 1,068,935 Nov 28, 2014, 04:31 PM
Alafi Christopher D Director Nov 19, 2014 Buy $14.25 1,034 14,735 3,559,783 Nov 21, 2014, 06:04 PM
ALAFI MOSHE 10% Owner Nov 19, 2014 Buy $14.25 1,034 14,735 3,559,783 Nov 21, 2014, 06:00 PM
ALAFI CAPITAL CO LLC 10% Owner Nov 19, 2014 Buy $14.25 1,034 14,735 3,559,783 Nov 21, 2014, 05:58 PM
Alafi Christopher D Director Nov 18, 2014 Buy $14.23 3,531 50,246 3,558,749 Nov 18, 2014, 05:46 PM
Alafi Christopher D Director Nov 14, 2014 Buy $15.07 133 2,004 3,555,218 Nov 18, 2014, 05:46 PM
ALAFI MOSHE 10% Owner Nov 18, 2014 Buy $14.23 3,531 50,246 3,558,749 Nov 18, 2014, 05:45 PM
ALAFI MOSHE 10% Owner Nov 14, 2014 Buy $15.07 133 2,004 3,555,218 Nov 18, 2014, 05:45 PM
ALAFI CAPITAL CO LLC 10% Owner Nov 18, 2014 Buy $14.23 3,531 50,246 3,558,749 Nov 18, 2014, 05:43 PM
ALAFI CAPITAL CO LLC 10% Owner Nov 14, 2014 Buy $15.07 133 2,004 3,555,218 Nov 18, 2014, 05:43 PM
Alafi Christopher D Director Nov 12, 2014 Buy $15.23 5,000 76,150 3,552,885 Nov 13, 2014, 05:04 PM
Alafi Christopher D Director Nov 11, 2014 Buy $15.55 5,000 77,750 3,547,885 Nov 13, 2014, 05:04 PM
Alafi Christopher D Director Nov 13, 2014 Buy $15.12 2,200 33,264 3,555,085 Nov 13, 2014, 05:04 PM
ALAFI MOSHE 10% Owner Nov 13, 2014 Buy $15.12 2,200 33,264 3,555,085 Nov 13, 2014, 05:01 PM
ALAFI MOSHE 10% Owner Nov 12, 2014 Buy $15.23 5,000 76,150 3,552,885 Nov 13, 2014, 05:01 PM
ALAFI MOSHE 10% Owner Nov 11, 2014 Buy $15.55 5,000 77,750 3,547,885 Nov 13, 2014, 05:01 PM
ALAFI CAPITAL CO LLC 10% Owner Nov 12, 2014 Buy $15.23 5,000 76,150 3,552,885 Nov 13, 2014, 04:59 PM
ALAFI CAPITAL CO LLC 10% Owner Nov 11, 2014 Buy $15.55 5,000 77,750 3,547,885 Nov 13, 2014, 04:59 PM
ALAFI CAPITAL CO LLC 10% Owner Nov 13, 2014 Buy $15.12 2,200 33,264 3,555,085 Nov 13, 2014, 04:59 PM
Halstead Michael SVP and General Counsel Nov 06, 2014 Buy $15.47 13,000 201,110 20,000 Nov 06, 2014, 04:53 PM
Halstead Michael SVP and General Counsel Nov 05, 2014 Buy $15.21 7,000 106,470 7,000 Nov 06, 2014, 04:53 PM
Wennogle Lawrence P. Vice President, Drug Discovery Oct 16, 2014 Sale $15.00 5,152 77,280 104,000 Oct 17, 2014, 05:00 PM
Wennogle Lawrence P. Vice President, Drug Discovery Oct 15, 2014 Sale $15.00 2,004 30,060 109,152 Oct 15, 2014, 04:52 PM
Wennogle Lawrence P. Vice President, Drug Discovery Oct 13, 2014 Sale $15.00 1,600 24,000 111,156 Oct 15, 2014, 04:52 PM
Wennogle Lawrence P. Vice President, Drug Discovery Oct 08, 2014 Sale $15.00 4,745 71,175 112,756 Oct 10, 2014, 05:05 PM
Wennogle Lawrence P. Vice President, Drug Discovery Oct 03, 2014 Sale $15.00 15,863 237,945 118,137 Oct 07, 2014, 04:30 PM
Wennogle Lawrence P. Vice President, Drug Discovery Oct 06, 2014 Sale $15.00 636 9,540 117,501 Oct 07, 2014, 04:30 PM
Wennogle Lawrence P. Vice President, Drug Discovery Sep 15, 2014 Sale $15.00 5,000 75,000 134,000 Sep 17, 2014, 05:12 PM
Hineline Lawrence J. VP of Finance CFO Sep 08, 2014 Option Exercise $0.50 300 150 50,300 Sep 10, 2014, 05:33 PM
Hineline Lawrence J. VP of Finance CFO Sep 08, 2014 Sale $15.00 300 4,500 50,000 Sep 10, 2014, 05:33 PM
Wennogle Lawrence P. Vice President, Drug Discovery Jul 21, 2014 Option Exercise $0.50 37,500 18,750 139,000 Jul 22, 2014, 05:31 PM
ALAFI MOSHE 10% Owner Jun 19, 2014 Sale $6.35 15,742 100,006 0 Jul 10, 2014, 04:56 PM
Fienberg Allen A. VP of Business Development May 28, 2014 Option Exercise $0.50 37,500 18,750 275,000 Jun 06, 2014, 05:23 PM
Wennogle Lawrence P. Vice President, Drug Discovery May 27, 2014 Sale $15.00 5,000 75,000 101,500 May 29, 2014, 06:30 PM
Wennogle Lawrence P. Vice President, Drug Discovery May 22, 2014 Sale $15.00 6,000 89,983 110,806 May 23, 2014, 07:46 PM
RIGGS RORY B Director Feb 05, 2014 Buy $17.50 28,571 499,993 240,955 Feb 05, 2014, 04:56 PM

Desktop Version

Owner Relationship Date Transaction Value($)
Alafi Christopher D Director May 14, 2019 Buy 1,256,350
Alafi Christopher D Director Mar 31, 2019 Option Exercise 14,494
VAN NOSTRAND ROBERT L Director Mar 31, 2019 Option Exercise 5,822
RIGGS RORY B Director Mar 31, 2019 Option Exercise 14,494
LERNER RICHARD A Director Mar 31, 2019 Option Exercise 13,739
Hineline Lawrence J. SVP of Finance CFO Feb 27, 2019 Option Exercise 28,496
Hineline Lawrence J. SVP of Finance CFO Feb 27, 2019 Sale 15,000
Mates Sharon Chairman, President & CEO Jan 07, 2019 Sale 82,088
Mates Sharon Chairman, President & CEO Jan 04, 2019 Sale 522,222
Halstead Michael EVP and General Counsel Jan 07, 2019 Sale 38,601
Halstead Michael EVP and General Counsel Jan 04, 2019 Sale 245,817
Hineline Lawrence J. SVP of Finance CFO Jan 07, 2019 Sale 38,601
Hineline Lawrence J. SVP of Finance CFO Jan 04, 2019 Sale 245,782
Vanover Kimberly E. SVP, Early Stage Clinical Dev. Jan 07, 2019 Sale 7,276
Vanover Kimberly E. SVP, Early Stage Clinical Dev. Jan 04, 2019 Sale 109,704
Davis Robert E SVP, Chief Scientific Officer Jan 04, 2019 Sale 109,630
Mates Sharon Chairman, President & CEO Jan 02, 2019 Sale 193,831
Halstead Michael EVP and General Counsel Jan 02, 2019 Sale 86,580
Vanover Kimberly E. SVP, Early Stage Clinical Dev. Jan 02, 2019 Sale 53,657
Davis Robert E SVP, Chief Scientific Officer Jan 02, 2019 Sale 53,706
Hineline Lawrence J. SVP of Finance CFO Jan 02, 2019 Sale 86,580
VAN NOSTRAND ROBERT L Director Dec 31, 2018 Option Exercise 5,832
RIGGS RORY B Director Dec 31, 2018 Option Exercise 14,499
LERNER RICHARD A Director Dec 31, 2018 Option Exercise 13,748
Alafi Christopher D Director Dec 31, 2018 Option Exercise 14,499
Mates Sharon Chairman, President & CEO Dec 10, 2018 Option Exercise 75,000
Davis Robert E SVP, Chief Scientific Officer Dec 06, 2018 Sale 12,163
MARCUS JOEL S Director Nov 12, 2018 Sale 125,580
MARCUS JOEL S Director Nov 09, 2018 Sale 456,000
LERNER RICHARD A Director Oct 22, 2018 Option Exercise 18,750
LERNER RICHARD A Director Sep 30, 2018 Option Exercise 13,736
RIGGS RORY B Director Sep 30, 2018 Option Exercise 14,496
VAN NOSTRAND ROBERT L Director Sep 30, 2018 Option Exercise 5,816
Alafi Christopher D Director Sep 30, 2018 Option Exercise 14,496
LERNER RICHARD A Director Jun 29, 2018 Option Exercise 13,747
Alafi Christopher D Director Jun 29, 2018 Option Exercise 14,489
VAN NOSTRAND ROBERT L Director Jun 29, 2018 Option Exercise 4,983
RIGGS RORY B Director Jun 29, 2018 Option Exercise 14,489
VAN NOSTRAND ROBERT L Director Mar 30, 2018 Option Exercise 4,989
LERNER RICHARD A Director Mar 30, 2018 Option Exercise 13,746
Alafi Christopher D Director Mar 30, 2018 Option Exercise 14,482
RIGGS RORY B Director Mar 30, 2018 Option Exercise 14,482
Hineline Lawrence J. VP of Finance CFO Feb 16, 2018 Sale 326,543
Hineline Lawrence J. VP of Finance CFO Feb 15, 2018 Sale 668,621
Halstead Michael SVP and General Counsel Jan 22, 2018 Sale 459,765
Vanover Kimberly E. SVP, Clinical Development Jan 08, 2018 Sale 13,479
Mates Sharon Chairman, President & CEO Jan 08, 2018 Sale 115,438
Mates Sharon Chairman, President & CEO Jan 05, 2018 Sale 192,270
Vanover Kimberly E. SVP, Clinical Development Jan 05, 2018 Sale 20,583
Davis Robert E SVP, Chief Scientific Officer Jan 04, 2018 Sale 17,394
Hineline Lawrence J. VP of Finance CFO Jan 04, 2018 Sale 50,019
Hineline Lawrence J. VP of Finance CFO Jan 05, 2018 Sale 32,706
Halstead Michael SVP and General Counsel Jan 05, 2018 Sale 27,284
Halstead Michael SVP and General Counsel Jan 04, 2018 Sale 41,895
VAN NOSTRAND ROBERT L Director Dec 29, 2017 Option Exercise 4,996
RIGGS RORY B Director Dec 29, 2017 Option Exercise 14,494
LERNER RICHARD A Director Dec 29, 2017 Option Exercise 13,742
Alafi Christopher D Director Dec 29, 2017 Option Exercise 14,494
VAN NOSTRAND ROBERT L Director Dec 29, 2017 Buy 4,996
LERNER RICHARD A Director Dec 29, 2017 Buy 13,742
RIGGS RORY B Director Dec 29, 2017 Buy 14,494
Alafi Christopher D Director Dec 29, 2017 Buy 14,494
LERNER RICHARD A Director Dec 11, 2017 Option Exercise 18,750
LERNER RICHARD A Director Dec 11, 2017 Sale 105,630
Davis Robert E SVP, Chief Scientific Officer Dec 05, 2017 Sale 9,750
Alafi Christopher D Director Nov 22, 2017 Buy 155,500
Mates Sharon Chairman, President & CEO Oct 30, 2017 Option Exercise 28,125
Mates Sharon Chairman, President & CEO Oct 30, 2017 Sale 295,313
ALAFI MOSHE 10% Owner Oct 02, 2017 Buy 4,000,008
Alafi Christopher D Director Oct 02, 2017 Buy 4,000,008
ALAFI CAPITAL CO LLC 10% Owner Oct 02, 2017 Buy 4,000,008
MARCUS JOEL S Director Jan 26, 2017 Option Exercise 247,450
Vanover Kimberly E. SVP, Clinical Development Jan 05, 2017 Sale 13,272
Mates Sharon Chairman, President & CEO Jan 05, 2017 Sale 67,541
Hineline Lawrence J. VP of Finance CFO Jan 05, 2017 Sale 31,800
Halstead Michael SVP and General Counsel Jan 05, 2017 Sale 26,497
Vanover Kimberly E. SVP, Clinical Development Dec 15, 2016 Option Exercise 27,425
Vanover Kimberly E. SVP, Clinical Development Dec 15, 2016 Sale 142,773
ALAFI MOSHE 10% Owner Dec 07, 2016 Buy 336,038
ALAFI MOSHE 10% Owner Dec 06, 2016 Buy 721,445
Alafi Christopher D Director Dec 06, 2016 Buy 721,445
Alafi Christopher D Director Dec 07, 2016 Buy 336,038
ALAFI CAPITAL CO LLC 10% Owner Dec 07, 2016 Buy 336,038
ALAFI CAPITAL CO LLC 10% Owner Dec 06, 2016 Buy 721,445
ALAFI MOSHE 10% Owner Nov 14, 2016 Buy 492,969
ALAFI CAPITAL CO LLC 10% Owner Nov 14, 2016 Buy 492,969
Alafi Christopher D Director Nov 14, 2016 Buy 492,969
RIGGS RORY B Director Feb 05, 2014 Buy 249,988
RIGGS RORY B Director Feb 05, 2014 Buy 250,005
Alafi Christopher D Director Feb 29, 2016 Buy 2,970,300
LERNER RICHARD A Director Feb 18, 2016 Option Exercise 13,600
VAN NOSTRAND ROBERT L Director Dec 31, 2015 Option Exercise 3,712
RIGGS RORY B Director Dec 31, 2015 Option Exercise 10,597
MARCUS JOEL S Director Dec 31, 2015 Option Exercise 10,704
Alafi Christopher D Director Dec 31, 2015 Option Exercise 10,489
LERNER RICHARD A Director Dec 31, 2015 Option Exercise 10,113
Mates Sharon Chairman, President & CEO Dec 11, 2015 Option Exercise 77,125
Mates Sharon Chairman, President & CEO Dec 11, 2015 Sale 2,774,441
Hineline Lawrence J. VP of Finance CFO Nov 24, 2015 Option Exercise 3,000
Hineline Lawrence J. VP of Finance CFO Dec 15, 2015 Option Exercise 50,750
Hineline Lawrence J. VP of Finance CFO Dec 14, 2015 Option Exercise 4,500
Hineline Lawrence J. VP of Finance CFO Dec 15, 2015 Sale 1,169,226
Hineline Lawrence J. VP of Finance CFO Dec 14, 2015 Sale 1,146,140
MARCUS JOEL S Director Dec 07, 2015 Sale 2,126,628
MARCUS JOEL S Director Dec 04, 2015 Sale 1,678,800
MARCUS JOEL S Director Dec 08, 2015 Sale 1,243,960
Hineline Lawrence J. VP of Finance CFO Nov 24, 2015 Sale 275,000
Fienberg Allen A. VP of Business Development Sep 09, 2015 Option Exercise 17,000
Fienberg Allen A. VP of Business Development Aug 19, 2015 Sale 303,000
Fienberg Allen A. VP of Business Development Aug 21, 2015 Sale 6,060
Wennogle Lawrence P. Vice President, Drug Discovery Jun 08, 2015 Sale 671,000
Wennogle Lawrence P. Vice President, Drug Discovery May 19, 2015 Option Exercise 58,250
Fienberg Allen A. VP of Business Development Mar 31, 2015 Option Exercise 7,500
MARCUS JOEL S Director Mar 31, 2015 Option Exercise 18,400
Alafi Christopher D Director Mar 11, 2015 Buy 15,000,000
Fienberg Allen A. VP of Business Development Jan 14, 2015 Sale 95,000
Hineline Lawrence J. VP of Finance CFO Dec 09, 2014 Sale 190,558
Hineline Lawrence J. VP of Finance CFO Dec 08, 2014 Sale 185,418
Hineline Lawrence J. VP of Finance CFO Dec 02, 2014 Option Exercise 18,600
Alafi Christopher D Director Dec 01, 2014 Buy 20,975
ALAFI MOSHE 10% Owner Dec 01, 2014 Buy 20,975
ALAFI CAPITAL CO LLC 10% Owner Dec 01, 2014 Buy 20,975
ALAFI CAPITAL CO LLC 10% Owner Nov 28, 2014 Buy 516,250
ALAFI MOSHE 10% Owner Nov 28, 2014 Buy 516,250
Alafi Christopher D Director Nov 28, 2014 Buy 516,250
Mates Sharon Chairman, President & CEO Nov 25, 2014 Option Exercise 25,000
Mates Sharon Chairman, President & CEO Nov 28, 2014 Sale 516,250
Alafi Christopher D Director Nov 19, 2014 Buy 14,735
ALAFI MOSHE 10% Owner Nov 19, 2014 Buy 14,735
ALAFI CAPITAL CO LLC 10% Owner Nov 19, 2014 Buy 14,735
Alafi Christopher D Director Nov 18, 2014 Buy 50,246
Alafi Christopher D Director Nov 14, 2014 Buy 2,004
ALAFI MOSHE 10% Owner Nov 18, 2014 Buy 50,246
ALAFI MOSHE 10% Owner Nov 14, 2014 Buy 2,004
ALAFI CAPITAL CO LLC 10% Owner Nov 18, 2014 Buy 50,246
ALAFI CAPITAL CO LLC 10% Owner Nov 14, 2014 Buy 2,004
Alafi Christopher D Director Nov 12, 2014 Buy 76,150
Alafi Christopher D Director Nov 11, 2014 Buy 77,750
Alafi Christopher D Director Nov 13, 2014 Buy 33,264
ALAFI MOSHE 10% Owner Nov 13, 2014 Buy 33,264
ALAFI MOSHE 10% Owner Nov 12, 2014 Buy 76,150
ALAFI MOSHE 10% Owner Nov 11, 2014 Buy 77,750
ALAFI CAPITAL CO LLC 10% Owner Nov 12, 2014 Buy 76,150
ALAFI CAPITAL CO LLC 10% Owner Nov 11, 2014 Buy 77,750
ALAFI CAPITAL CO LLC 10% Owner Nov 13, 2014 Buy 33,264
Halstead Michael SVP and General Counsel Nov 06, 2014 Buy 201,110
Halstead Michael SVP and General Counsel Nov 05, 2014 Buy 106,470
Wennogle Lawrence P. Vice President, Drug Discovery Oct 16, 2014 Sale 77,280
Wennogle Lawrence P. Vice President, Drug Discovery Oct 15, 2014 Sale 30,060
Wennogle Lawrence P. Vice President, Drug Discovery Oct 13, 2014 Sale 24,000
Wennogle Lawrence P. Vice President, Drug Discovery Oct 08, 2014 Sale 71,175
Wennogle Lawrence P. Vice President, Drug Discovery Oct 03, 2014 Sale 237,945
Wennogle Lawrence P. Vice President, Drug Discovery Oct 06, 2014 Sale 9,540
Wennogle Lawrence P. Vice President, Drug Discovery Sep 15, 2014 Sale 75,000
Hineline Lawrence J. VP of Finance CFO Sep 08, 2014 Option Exercise 150
Hineline Lawrence J. VP of Finance CFO Sep 08, 2014 Sale 4,500
Wennogle Lawrence P. Vice President, Drug Discovery Jul 21, 2014 Option Exercise 18,750
ALAFI MOSHE 10% Owner Jun 19, 2014 Sale 100,006
Fienberg Allen A. VP of Business Development May 28, 2014 Option Exercise 18,750
Wennogle Lawrence P. Vice President, Drug Discovery May 27, 2014 Sale 75,000
Wennogle Lawrence P. Vice President, Drug Discovery May 22, 2014 Sale 89,983
RIGGS RORY B Director Feb 05, 2014 Buy 499,993